This Friday, a new method of radiation therapy for tumors that will use high-energy electron radiation was presented at a Swiss hospital, where it is expected to start operating around 2025.
As an important advance in the field of oncology, the treatment should increase the effectiveness of radiation therapy, reduce costs and reduce the impact of radiation on the human body to a few milliseconds, thereby reducing possible side effects.
The high-energy electrons are similar to those tested at CERN, the European Organization for Nuclear Research, which participated in research into a new therapy presented at a ceremony at the Vaudois University Hospital Center (CHUV) in Lausanne.
According to the Spanish news agency EFE, it is in this hospital that a special “bunker” will be built for the device used in the treatment.
The device is based on Flash technology, which uses very high energy electrons (VHEE, its abbreviation in English) studied 10 years ago to try to treat cancers that are resistant to conventional radiation treatments, which currently account for a third of the total.
Initially, the treatment was tested on shallow tumors, less than three centimeters from the skin, using the FLASHKNiFE program, but specialists were able to increase the depth to 20 centimeters in the second stage, called FLASHDEEP, which would reach almost all solid tumors. .
In June, the Centro Hospitalar Universitário Lisboa Norte (CHULN) announced that it would join a European project to test the clinical application of a method called Pulsed Radiation Therapy in Skin Cancer Patients.
“Pulsed radiation therapy” allows only one treatment session for each patient, CHULN, made up of the Santa Maria and Pulido Valente hospitals and the only Portuguese hospital center part of the international consortium FLASHKNiFE, said in a statement.
The Flash-based radiotherapy machine, the first of its kind in the world, will be built by THERYQ, part of the French industrial consortium ALCEN, and the research program was carried out thanks to an investment of 26 million euros. According to the Dutch medical foundation Biltema, EFE reports.
Author: Portuguese
Source: CM Jornal
I am Michael Melvin, an experienced news writer with a passion for uncovering stories and bringing them to the public. I have been working in the news industry for over five years now, and my work has been published on multiple websites. As an author at 24 News Reporters, I cover world section of current events stories that are both informative and captivating to read.